Naoki Okamura works as a President and CEO at Astellas Pharma. The firm's known portfolio counts 9 companies.
Is Naoki Okamura a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-StageSeries A
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
President and CEO at Astellas Pharma, whose known portfolio counts 9 companies
- Catalia Health
- Poseida Therapeutics
- Taysha Gene Therapies
- AviadoBio
- Iota Biosciences
- Mitobridge
- Vir Biotechnology
- LabCentral
- National Comprehensive Cancer Network (NCCN)
Investor Profile
Naoki Okamura is listed against sector Healthcare, and focus areas Biotech, Drug Discovery, Gene Therapy and Genomics in the database.
Stage-wise, the deals at Astellas Pharma cluster around Late-Stage and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Naoki Okamura is worth approaching.
Colleagues at Astellas Pharma
Richard Svinkin
AI Product Mgt., Angel Investor
New York, United States
Catherine Lee
Investor
Mons, Belgium
Wo Bao Bu Chuan Hao Jiang Shi Hao
Investor
London, United Kingdom
Catherine Lai
Investor
United Kingdom
Alexandra Procak
Investor
Tampa, United States
Frequently asked questions
Who is Naoki Okamura?
Naoki Okamura is a corporate venture investor based in Tokyo, Japan, listed as President and CEO at Astellas Pharma. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Naoki Okamura personally.
What does Naoki Okamura invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Gene Therapy and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Naoki Okamura invest at?
Astellas Pharma appears in Late-Stage and Series A rounds across its known deals, and Naoki Okamura is listed there as President and CEO. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Naoki Okamura listed at?
Naoki Okamura is listed as President and CEO at Astellas Pharma. 5 other people in the database share a firm with Naoki Okamura.
How do I contact Naoki Okamura?
A LinkedIn page is on file for Naoki Okamura. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal